In the time it has taken you to read this article, 40 people in the world have experienced eosinophilic asthma or COPD flare-up. Under current best treatments, 30 of them will require further care ...

COPD is the third leading cause of death worldwide ... we'll make sure that families everywhere never face a lung condition without the best treatment and care." More information: Monoclonal ...

If you're not paying close attention, the first stage can be easy to miss. COPD treatment goal is to help you breathe easier and help regular activities. Medications along with lifestyle ...

The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual condition management.

Immunoglobulin G hypogammaglobulinemia was found in 44.7% of patients with acute exacerbations of COPD receiving triple ...

The new treatment, the Zephyr Valve ... St. Vincents Riverside was named a High Performing Hospital for COPD care and a Best Regional Hospital by the U.S. News and World Report’s Best Hospital ...

Share on Pinterest GLP-1 and SGLT-2 drugs may be the best treatments for people with type 2 diabetes and COPD. Image credit: Visual Vic/Getty Images. Researchers estimate the number of people ...

COPD is a syndrome akin to asthma but with important differences, including tobacco smoke-induced pathobiology and pulmonary emphysema. An exploration of how best to define ACOS is beyond the ...

Conclusion. In the treatment of COPD exacerbations, systemic corticosteroids improve airflow limitations, decrease treatment failure rates, decrease the risk of relapse, and may improve symptoms ...

People with COPD have a higher risk of developing pneumonia due to changes in their lung microbiome. Early detection and treatment could help reduce the risk of complications. Chronic obstructive ...

“This could influence treatment decisions and improve respiratory health in this high-risk population.” “GLP-1 medications might help lower COPD exacerbation risk by reducing systemic ...